HCW Biologics Inc.
HCWB· Nasdaq
HCWBHCW Biologics Inc.
Filed Mar 28, 2023 · 10-K · 87 days after period end · 0000950170-23-010315
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures |
|---|---|---|---|
| Revenue | $1.34M | $0.00 | — |
| Net Income | -$5.42M | -$3.17M | $2.06M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
HCW Biologics Inc. · CIK 1828673 · Engraved from SEC EDGAR
ended Dec 31, 2022 · filed Mar 28, 2023 · 87 d after period end
